Show simple item record

Diagnosis and prevalence of diabetic polyneuropathy: a cross‐sectional study of Danish patients with type 2 diabetes

dc.contributor.authorGylfadottir, S. S.
dc.contributor.authorItani, M.
dc.contributor.authorKrøigxiård, T.
dc.contributor.authorKristensen, A. G.
dc.contributor.authorChristensen, D. H.
dc.contributor.authorNicolaisen, S. K.
dc.contributor.authorKarlsson, P.
dc.contributor.authorCallaghan, B. C.
dc.contributor.authorBennett, D. L.
dc.contributor.authorAndersen, H.
dc.contributor.authorTankisi, H.
dc.contributor.authorNielsen, J. S.
dc.contributor.authorAndersen, N. T.
dc.contributor.authorJensen, T. S.
dc.contributor.authorThomsen, R. W.
dc.contributor.authorSindrup, S. H.
dc.contributor.authorFinnerup, N. B.
dc.date.accessioned2020-12-02T14:41:07Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-12-02T14:41:07Z
dc.date.issued2020-12
dc.identifier.citationGylfadottir, S. S.; Itani, M.; Krøigård, T. ; Kristensen, A. G.; Christensen, D. H.; Nicolaisen, S. K.; Karlsson, P.; Callaghan, B. C.; Bennett, D. L.; Andersen, H.; Tankisi, H.; Nielsen, J. S.; Andersen, N. T.; Jensen, T. S.; Thomsen, R. W.; Sindrup, S. H.; Finnerup, N. B. (2020). "Diagnosis and prevalence of diabetic polyneuropathy: a cross‐sectional study of Danish patients with type 2 diabetes." European Journal of Neurology 27(12): 2575-2585.
dc.identifier.issn1351-5101
dc.identifier.issn1468-1331
dc.identifier.urihttps://hdl.handle.net/2027.42/163624
dc.publisherJohn Wiley and Sons
dc.subject.otherprevalence
dc.subject.otherdiabetes
dc.subject.otherdiagnosis
dc.subject.otherneuropathic pain
dc.subject.otherpolyneuropathy
dc.titleDiagnosis and prevalence of diabetic polyneuropathy: a cross‐sectional study of Danish patients with type 2 diabetes
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelNeurosciences
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163624/2/ene14469.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/163624/1/ene14469_am.pdfen_US
dc.identifier.doi10.1111/ene.14469
dc.identifier.sourceEuropean Journal of Neurology
dc.identifier.citedreferenceTankisi H, Pugdahl K, Beniczky S, Andersen H, Fuglsang‐Frederiksen A. Evidence‐based recommendations for examination and diagnostic strategies of polyneuropathy electrodiagnosis. Clin Neurophysiol Pract 2019; 4: 214 – 222.
dc.identifier.citedreferenceFeldman EL, Nave KA, Jensen TS, Bennett DLH. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron 2017; 93: 1296 – 1313.
dc.identifier.citedreferenceAndersen ST, Witte DR, Dalsgaard EM, et al. Risk factors for incident diabetic polyneuropathy in a cohort with screen‐detected type 2 diabetes followed for 13 years: ADDITION‐Denmark. Diabetes Care 2018; 41: 1068 – 1075.
dc.identifier.citedreferenceTruini A, Spallone V, Morganti R, et al. A cross sectional study investigating frequency and features of definitely diagnosed diabetic painful polyneuropathy. Pain 2018; 159: 2658 – 2666.
dc.identifier.citedreferenceZiegler D, Strom A, Lobmann R, Reiners K, Rett K, Schnell O. High prevalence of diagnosed and undiagnosed polyneuropathy in subjects with and without diabetes participating in a nationwide educational initiative (PROTECT study). J Diabetes Complications 2015; 29: 998 – 1002.
dc.identifier.citedreferenceFeldman EL, Callaghan BC, Pop‐Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers 2019; 5: 41.
dc.identifier.citedreferenceDyck PJ, Overland CJ, Low PA, et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve 2010; 42: 157 – 164.
dc.identifier.citedreferenceFinnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain 2016; 157: 1599 – 1606.
dc.identifier.citedreferenceTesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285 – 2293.
dc.identifier.citedreferenceEngland JD, Gronseth GS, Franklin G, et al. Distal symmetrical polyneuropathy: a definition for clinical research. A report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Arch Phys Med Rehabil 2005; 86: 167 – 174.
dc.identifier.citedreferencevan Hecke O, Kamerman PR, Attal N, et al. Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi survey, and expert panel recommendations. Pain 2015; 156: 2337 – 2353.
dc.identifier.citedreferenceHerman WH, Pop‐Busui R, Braffett BH, et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med 2012; 29: 937 – 944.
dc.identifier.citedreferenceFeldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two‐step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281 – 1289.
dc.identifier.citedreferenceSpallone V, Morganti R, D’Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med 2012; 29: 578 – 585.
dc.identifier.citedreferenceErbas T, Ertas M, Yucel A, Keskinaslan A, Senocak M. Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients. J Clin Neurophysiol 2011; 28: 51 – 55.
dc.identifier.citedreferenceGylfadottir SS, Christensen DH, Nicolaisen SK, et al. Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross‐sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes. Pain 2020; 161: 574 – 583.
dc.identifier.citedreferenceFeldman EL, Stevens MJ. Clinical testing in diabetic peripheral neuropathy. Can J Neurol Sci 1994; 21: S3 – S7.
dc.identifier.citedreferenceBouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114: 29 – 36.
dc.identifier.citedreferencePerkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001; 24: 250 – 256.
dc.identifier.citedreferenceBril V, Perkins BA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 2002; 25: 2048 – 2052.
dc.identifier.citedreferenceSingleton JR, Bixby B, Russell JW, et al. The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst 2008; 13: 218 – 227.
dc.identifier.citedreferenceCosta YM, Karlsson P, Bonjardim LR, et al. Trigeminal nociceptive function and oral somatosensory functional and structural assessment in patients with diabetic peripheral neuropathy. Sci Rep 2019; 9: 169.
dc.identifier.citedreferenceLauria G, Bakkers M, Schmitz C, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010; 15: 202 – 207.
dc.identifier.citedreferenceRolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006; 123: 231 – 243.
dc.identifier.citedreferenceMagerl W, Krumova EK, Baron R, Tolle T, Treede RD, Maier C. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain 2010; 151: 598 – 605.
dc.identifier.citedreferenceThompson SK. Sampling, 3 rd edn. Hoboken, NJ: John Wiley and Sons, 2012.
dc.identifier.citedreferencePop‐Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 2017; 40: 136 – 154.
dc.identifier.citedreferenceGylfadottir SS, Weeracharoenkul D, Andersen ST, Niruthisard S, Suwanwalaikorn S, Jensen TS. Painful and non‐painful diabetic polyneuropathy: clinical characteristics and diagnostic issues. J Diabetes Investig 2019; 10: 1148 – 1157.
dc.identifier.citedreferenceCallaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: a review. JAMA 2015; 314: 2172 – 2181.
dc.identifier.citedreferenceSpallone V, Greco C. Painful and painless diabetic neuropathy: one disease or two? Curr Diab Rep 2013; 13: 533 – 549.
dc.identifier.citedreferenceZilliox LA, Ruby SK, Singh S, Zhan M, Russell JW. Clinical neuropathy scales in neuropathy associated with impaired glucose tolerance. J Diabetes Complications 2015; 29: 372 – 377.
dc.identifier.citedreferenceKarlsson P, Nyengaard JR, Polydefkis M, Jensen TS. Structural and functional assessment of skin nerve fibres in small‐fibre pathology. Eur J Pain 2015; 19: 1059 – 1070.
dc.identifier.citedreferenceChristensen DH, Nicolaisen SK, Berencsi K, et al. Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile. BMJ Open 2018; 8: e017273.
dc.identifier.citedreferenceGedebjerg A, Almdal TP, Berencsi K, et al. Prevalence of micro‐ and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: a cross‐sectional baseline study of 6958 patients in the Danish DD2 cohort. J Diabetes Complications 2018; 32: 34 – 40.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.